Quick Answer
BIOGEN INC. reported Total Assets of $29.44 billion for the year ending 2025.
- BIOGEN INC. showed an increase of +5.0% in Total Assets from 2024 to 2025.
- This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2009: $8.78 billion | Q3 2009: $9.03 billion | Q1 2010: $8.22 billion | Q2 2010: $7.50 billion | Q3 2010: $7.39 billion | Q1 2011: $8.29 billion | Q2 2011: $8.62 billion | Q3 2011: $8.80 billion | Q1 2012: $9.11 billion | Q2 2012: $9.16 billion | Q3 2012: $9.63 billion | Q1 2013: $10.16 billion | Q2 2013: $10.84 billion | Q3 2013: $11.25 billion | Q1 2014: $12.23 billion | Q2 2014: $12.92 billion | Q3 2014: $13.70 billion | Q1 2015: $15.22 billion | Q2 2015: $16.76 billion | Q3 2015: $20.73 billion | Q1 2016: $20.67 billion | Q2 2016: $21.51 billion | Q3 2016: $22.10 billion | Q1 2017: $21.20 billion | Q2 2017: $21.76 billion | Q3 2017: $23.07 billion | Q1 2018: $26.09 billion | Q2 2018: $23.95 billion | Q3 2018: $25.49 billion | Q1 2019: $26.45 billion | Q2 2019: $26.29 billion | Q3 2019: $27.48 billion | Q1 2020: $26.12 billion | Q2 2020: $25.51 billion | Q3 2020: $24.93 billion | Q1 2021: $23.85 billion | Q2 2021: $24.47 billion | Q3 2021: $23.81 billion | Q1 2022: $23.61 billion | Q2 2022: $25.08 billion | Q3 2022: $24.85 billion | Q1 2023: $24.60 billion | Q2 2023: $25.16 billion | Q3 2023: $28.19 billion | Q1 2024: $26.57 billion | Q2 2024: $26.80 billion | Q3 2024: $28.31 billion | Q1 2025: $28.03 billion | Q2 2025: $28.33 billion | Q3 2025: $29.21 billion.
- Over the full 18 years of available data (2008 to 2025), BIOGEN INC.'s Total Assets has grown by 247.2%.
- Historical annual values: Fiscal year 2025: $29.44 billion | Fiscal year 2024: $28.05 billion | Fiscal year 2023: $26.84 billion | Fiscal year 2022: $24.55 billion | Fiscal year 2021: $23.88 billion | Fiscal year 2020: $24.62 billion | Fiscal year 2019: $27.23 billion | Fiscal year 2018: $25.29 billion | Fiscal year 2017: $23.65 billion | Fiscal year 2016: $22.88 billion | Fiscal year 2015: $19.50 billion | Fiscal year 2014: $14.31 billion | Fiscal year 2013: $11.86 billion | Fiscal year 2012: $10.13 billion | Fiscal year 2011: $9.05 billion | Fiscal year 2010: $8.09 billion | Fiscal year 2009: $8.55 billion | Fiscal year 2008: $8.48 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: